Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.8 DKK | -2.49% | +10.57% | -13.88% |
May. 08 | BioPorto A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Bioporto A/S Provides Earnings Guidance for 2024 | CI |
Sales 2024 * | 40M 5.83M | Sales 2025 * | - | Capitalization | 683M 99.56M |
---|---|---|---|---|---|
Net income 2024 * | -38M -5.54M | Net income 2025 * | - | EV / Sales 2024 * | 17.1 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-18
x | P/E ratio 2025 * |
-
| Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.17% |
Latest transcript on BioPorto A/S
1 day | -2.49% | ||
1 week | +10.57% | ||
Current month | +38.89% | ||
1 month | +43.54% | ||
3 months | -14.29% | ||
6 months | -23.73% | ||
Current year | -13.88% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 13-07-17 | |
Ursula Klause
CTO | Chief Tech/Sci/R&D Officer | - | 20-11-30 |
Prasad Devarajan
CTO | Chief Tech/Sci/R&D Officer | - | 22-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
John McDonough
CHM | Chairman | 65 | 21-04-28 |
Donnie Hardison
BRD | Director/Board Member | 74 | 21-04-28 |
Chief Executive Officer | 64 | 13-07-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 1.8 | -2.49% | 526,501 |
24-05-16 | 1.846 | +3.13% | 697,466 |
24-05-15 | 1.79 | +1.24% | 926,520 |
24-05-14 | 1.768 | -6.95% | 2,682,689 |
Delayed Quote Nasdaq Copenhagen, May 17, 2024 at 10:54 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.88% | 99.57M | |
-4.67% | 12.32B | |
-5.19% | 8.07B | |
+9.45% | 5.91B | |
+28.50% | 5.52B | |
-8.09% | 4.21B | |
-55.31% | 2.99B | |
+13.49% | 2.73B | |
-1.34% | 2.43B | |
+32.24% | 2.29B |
- Stock Market
- Equities
- BIOPOR Stock